Table 3.
Cox proportional hazard analysis of patient’s survival
| Variable | PFS | OS | ||||
|---|---|---|---|---|---|---|
| Relative risk (RR) | 95% CI | p value | Relative risk (RR) | 95% CI | p value | |
| PD-L1 | 0.98 | 0.96–1.00 | 0.01 | 0.99 | 0.97–1.02 | 0.63 |
| HGF baseline (pg/ml) | 1.08 | 0.96–1.11 | < 0.001 | 1.08 | 1.03–1.13 | 0.002 |
| HGF first evaluation | 1.02 | 0.91–1.15 | 0.74 | 1.03 | 0.82–1.30) | 0.826 |
| PS < 1 | 1.18 | 0.34–4.03 | 0.80 | 0.293 | 0.04–2.23) | 0.236 |
| Histology (Adenocarcinoma, ADK) | 0.10 | 0.0001–0.37 | < 0.001 | 0.10 | 0.000–0.43 | 0.002 |
| Metastasis < 2 | 2.13 | 0.78–5.76 | 0.14 | 0.80 | 0.22–2.82 | 0.72 |
| Presence of a mutation | 0.88 | 0.29–2.7 | 0.81 | 1.69 | 0.28–10.25 | 0.57 |